References
- Apte, S.S. and Parks, W.C., 2015. Metalloproteinases: a parade of functions in matrix biology and an outlook for the future. Matrix biology, 44–46, 1–6.
- Borger, M.A., et al., 2018. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: full online-only version. The journal of thoracic and cardiovascular surgery, 156 (2), e41–e74.
- Cho, W.C., 2010. MicroRNAs as therapeutic targets for lung cancer. Expert opinion on therapeutic targets, 14 (10), 1005–1008.
- Cotrufo, M., et al., 2005. Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: preliminary results. Journal of thoracic and cardiovascular surgery, 130 (2), 504–511.
- Elia, L., et al., 2009. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell death and differentiation, 16 (12), 1590–1598.
- Fedak, P.W.M., et al., 2002. Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve. Circulation, 106 (8), 900–904.
- Girdauskas, E., et al., 2020. Expression patterns of circulating microRNAs in the risk stratification of bicuspid aortopathy. Journal of clinical medicine, 9 (1), 276.
- Guzzardi, D.G., et al., 2015. Valve-related hemodynamics mediate human bicuspid aortopathy: insights from wall shear stress mapping. Journal of the American College of Cardiology, 66 (8), 892–900.
- Hiratzka, L.F., et al., 2016. Surgery for aortic dilatation in patients with bicuspid aortic valves: a statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 67 (6), 724–731.
- Ikonomidis, J.S., et al., 2013. Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. The journal of thoracic and cardiovascular surgery, 145 (5), 1326–1333.
- Jones, J.A., et al., 2011. Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circulation. Cardiovascular genetics, 4 (6), 605–613.
- Lujambio, A. and Lowe, S.W., 2012. The microcosmos of cancer. Nature, 482 (7385), 347–355.
- Nagase, H. and Woessner, J.F., 1999. Matrix metalloproteinases. The journal of biological chemistry, 274 (31), 21491–21494.
- Pape, L.A., et al., 2007. Aortic diameter ≧5.5 cm is not a good predictor of type A Aortic Dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation, 116 (10), 1120–1127.
- Rabkin, S.W., 2014. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis. VASA. Zeitschrift fur gefasskrankheiten, 43 (6), 433–442.
- Shi, L., et al., 2019. Effect of microRNA-133a-3p/matrix metalloproteinase-9 axis on the growth of atherosclerotic vascular smooth muscle cells . Experimental and therapeutic medicine, 18 (6), 4356–4362.
- Soler-Botija, C., Gálvez-Montón, C., and Bayés-Genís, A., 2019. Epigenetic biomarkers in cardiovascular diseases. Frontiers in genetics., 10, 1–31.
- Tsui, N.B.Y., Ng, E.K.O., and Lo, Y.M.D., 2002. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clinical chemistry, 48 (10), 1647–1653.
- Vempati, P., Karagiannis, E.D., and Popel, A.S., 2007. A biochemical model of matrix metalloproteinase 9 activation and inhibition. The journal of biological chemistry, 282 (52), 37585–37596.
- Weinsaft, J.W., et al., 2016. Aortic dissection in patients with genetically mediated aneurysms: incidence and predictors in the GenTAC Registry. Journal of the American College of Cardiology, 67 (23), 2744–2754.
- Wu, J., et al., 2016. Progressive aortic dilation is regulated by miR-17-associated miRNAs. Journal of the American College of Cardiology, 67 (25), 2965–2977.